Are you Dr. Mendrinos?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Rahway Ave
Union, NJ 07083Phone+1 800-440-7284
Summary
- Dr. Savvas Mendrinos, MD is a board certified pathologist in Union, New Jersey. He is currently licensed to practice medicine in New Jersey, Wisconsin, and New Hampshire.
Education & Training
- Harvard Medical SchoolClass of 2005
- Emory University School of MedicineFellowship, Cytopathology, 2002 - 2004
- Emory University School of MedicineResidency, Pathology-Anatomic and Clinical, 2000 - 2003
- Eastern Virginia Medical SchoolResidency, Pathology-Anatomic and Clinical, 1999 - 2000
Certifications & Licensure
- NH State Medical License 2017 - Present
- AR State Medical License 2015 - 2026
- VT State Medical License 2014 - 2026
- VA State Medical License 2005 - 2026
- TX State Medical License 2015 - 2026
- TN State Medical License 2014 - 2026
- RI State Medical License 2016 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsPTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcino...Rajal B. Shah, Karen T. Shore, Jiyoon Yoon, Savvas Mendrinos, Jesse K. McKenney
The Prostate. 2019-08-01 - 11 citationsImprovement of diagnostic agreement among pathologists in resolving an “atypical glands suspicious for cancer” diagnosis in prostate biopsies using a novel “Disease-Fo...Rajal B. Shah, Gioacchino Leandro, Gloria Romerocaces, James Bentley, Jiyoon Yoon
Human Pathology. 2016-10-01 - 7 citationsERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasiaRajal B. Shah, Jianbo Li, Nadeem N. Dhanani, Savvas Mendrinos
Urologic Oncology. 2016-03-01